HOME >> BIOLOGY >> NEWS
Alaska study offers strategies to mitigate climate warming

onment to significant social and ecological change. By increasing biological, cultural, and economic diversity the authors argue that humans will have more options for adapting to changes and that such diversity can act as a buffer from change.

The third strategy focuses on reducing human and environmental vulnerability by effectively communicating to the public how the effects of high-latitude (Arctic) climate warming are linked to their low-latitude causes. "The climate change impacts being experienced in Alaska can be responded to here, but most of their causes need to be addressed at the national or international level," said co-author Martin Robards, a UAF RAP Ph.D. student. Reducing the anthropogenic (human-caused) contribution to climate warming - greenhouse gas emissions - is the key to mitigating climate change-related vulnerability in Interior Alaska," write the authors.

The fourth strategy is to facilitate transformation. "People typically prefer to adopt an accustomed life, rather than perpetually adapting to sudden and rapid changes," Robards said. "Transformation is the ability of people to look at the changing world and their place in it in new and unknown ways." For example, rising oil prices makes transforming an Alaska village from diesel-based fuel to biomass more feasible.

Despite the challenges of sustaining the beneficial attributes of complex social-ecological systems in the face of multiple large-scale directional changes, including climate warming, the authors conclude that each of the strategies provides societal benefits and suggest that all be pursued simultaneously.


'"/>

Contact: Marie Gilbert
marie.gilbert@uaf.edu
907-474-7412
University of Alaska Fairbanks
5-Oct-2006


Page: 1 2

Related biology news :

1. Wolves of Alaska became extinct 12,000 years ago, scientists report
2. Specialized, bone-crushing wolves of Alaska disappeared long ago
3. Ice Age extinction claimed highly carnivorous Alaskan wolves
4. Academy paleontologist and Alaska artist in line for natural history awards
5. University of Alaska Fairbanks awarded $3.8M for bird flu research
6. Changing ocean conditions led to decline in Alaskas sea lion population
7. Alaska graduate receives nations top dissertation honor
8. Shrinking ponds signal warmer, dryer Alaska
9. Alaskans feel the heat of global warming
10. Alaska seal pup diet may hold key to decline of population
11. Alaska timber projection study reveals market trends

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Alaska study offers strategies mitigate climate warming

(Date:5/5/2015)... 5, 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, reminds investors and media that ... is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series ... is themed Global Fraud: Where is the Trust in ...
(Date:4/27/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces that its Wocket® Smart ... week of May, 2015 and will be fulfilling all ... Gino Pereira , Chief Executive Officer said, ... Wocket® enters the consumer market. We would like to ...
(Date:4/21/2015)... 2015 High crime rate, ... boosting access control systems market in Saudi ... recently published report by TechSci Research " Saudi Arabia Access ... control systems market in Saudi Arabia ... access control systems market in the Kingdom is growing ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3
(Date:5/21/2015)... , May 21, 2015  Prima Biomed Ltd. ... that is striving to become a leader in the ... recently announced that the final CVac data from the ... a clear trend for a clinically meaningful improvement in ... second remission patients. In the group of ...
(Date:5/21/2015)... 21, 2015 Imagine being able ... and those of others. Being able to read faces ... read people to anticipate their thoughts and actions like ... and feelings to create unique abstract paintings and video, ... Get inside a first-person-shooter as it creates action, dialog, ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: RP) ... focused on the development of autologous cell therapies, ... International Society for Cellular Therapy (ISCT) on RepliCel,s ... in a Phase 1/2 clinical trial.  The presentation, ... 5:30 PM to 7:00 PM local time, will ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 25 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3
Cached News: